CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 11 enrolled
Drug / intervention
Transcranial Direct Current Stimulation (tDCS) +1 moredevice
Likely dose
tDCS 2.0 mA delivered over 30 minutes (29 minutes constant + 30 second ramp) combined with word-naming activityAI-extracted
Key inclusion· 5
  • Diagnosis of primary progressive aphasia, logopenic or semantic variant subtype
  • PPVT score < -1.0 SD, confirming English language fluency and premorbid cognitive ability
  • WAIS-IV Matrix Reasoning T score < 20 to exclude severe cognitive impairment
  • Stable and continuous access to internet service and email (WiFi hotspot provided if needed)
Key exclusion· 7
  • Nonfluent/agrammatic subtype of primary progressive aphasia
  • Any disorder other than PPA known to cause language dysfunction
  • History of traumatic brain injury
  • Uncontrolled seizure disorder or recent (<5 years) history of seizure

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05615922
NCT05615922Phase 2Completed

Remotely Supervised Transcranial Direct Current Stimulation (tDCS) for Primary Progressive Aphasia (PPA)

NYU Langone Health·interventional·Posted Nov 14, 2022·Updated Sep 19, 2024

In Brief

A Phase 2 clinical trial evaluating Transcranial Direct Current Stimulation (tDCS) and Word-Naming Activity for Primary Progressive Aphasia. Completed, enrolled 11 participants across 1 site.

Detailed Summary

The purpose of this study is to establish the feasibility of a program of remotely supervised transcranial direct current stimulation (RS-tDCS) paired with language skills practice for people living with the semantic or logopenic variants of primary progressive aphasia (PPA). There are currently no established standard-of-care treatments for PPA. This study will evaluate whether RS-tDCS combined with language skills practice is a feasible study design for individuals with PPA.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2023202420252026
First PostedNov 14, 2022
Enrollment StartDec 24, 2022
Primary CompletionAug 14, 2023
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 3.6 years ago

Interventions

Transcranial Direct Current Stimulation (tDCS)device

tDCS is noninvasive brain stimulation device that modulates brain activity by delivering a low-intensity electrical current (2.0 mA) through scalp sponge electrodes. The device is preprogrammed to ramp up to 2.0 mA (for 30 seconds), provide constant current throughout session (29 minutes), and then ramp down (for 30 seconds) at the end.

Word-Naming Activitybehavioral

During each tDCS session, the tDCS clinician will guide the participant in a word-naming exercise. Participants will be presented with photos of target items and prompted to verbally produce the names of the pictures.